<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prognosis of patients with advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with <z:mp ids='MP_0000611'>icterus</z:mp> is dismally poor, and adequate chemotherapy for these patients has not been established yet </plain></SENT>
<SENT sid="1" pm="."><plain>A 59-year-old male with <z:mp ids='MP_0002899'>fatigue</z:mp>, <z:hpo ids='HP_0002039'>anorexia</z:hpo> and <z:mp ids='MP_0000611'>icterus</z:mp> with serum total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> 9.7 mg/dL was referred to our institution </plain></SENT>
<SENT sid="2" pm="."><plain>He was diagnosed with advanced sigmoid <z:hpo ids='HP_0003003'>colon cancer</z:hpo> with multiple <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A biopsy specimen of the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> showed well-differentiated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> without KRAS mutation </plain></SENT>
<SENT sid="4" pm="."><plain>Since biliary drainage was impossible due to diffuse <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>, we initiated combination chemotherapy with <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>, Leucovorin, <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> (modified FOLFOX6) and cetuximab </plain></SENT>
<SENT sid="5" pm="."><plain>The doses of <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> were reduced, but cetuximab was administered at the standard dosage </plain></SENT>
<SENT sid="6" pm="."><plain>After 3 courses of chemotherapy, total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> dropped to 0.8 mg/dL </plain></SENT>
<SENT sid="7" pm="."><plain>No significant toxicity other than grade-2 skin toxicity and <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> was observed, and the patient has continued chemotherapy on an outpatient basis </plain></SENT>
<SENT sid="8" pm="."><plain>Combination chemotherapy with mFOLFOX6 plus cetuximab was effective and feasible in this case of metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> with <z:mp ids='MP_0000611'>icterus</z:mp> due to diffuse <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
</text></document>